Stephen C. Rowe

STEPHEN C. ROWE, President & CEO, co-Founder, Infimed Therapeutics, Inc.
Stephen Rowe co-founded Infimed with Jeffrey A. Hubbell in 1998. Prior
to founding Infimed, Mr. Rowe played a key role in starting up a series
of biotech and medical device companies including Cell Genesys,
Cytotherapeutics, Endotex and Focal, Inc. Prior to Infimed and Focal,
Mr. Rowe was a Principal in the life sciences group of Mayfield Fund,
where he worked with Mark Levin, currently CEO of Millennium
Pharmaceutics. Mr. Rowe graduated from Harvard College with a BA in
Biochemistry and received a MBA from the University of California at
Berkeley.